Allelic complementation between MHC haplotypes B(Q) and B17 increases regression of Rous sarcomas

Area of Science:

• Immunogenetics
• Viral Oncology
• Avian Biology

Background:

• The Major Histocompatibility (B) complex plays a crucial role in immune responses.
• Rous sarcoma virus (RSV) is a well-established model for studying tumor development and immune evasion.

Purpose of the Study:

• To investigate the impact of specific Major Histocompatibility (B) complex haplotypes (B(Q) and B17) on the outcome of Rous sarcoma virus infection in chickens.
• To determine if genetic complementation occurs in heterozygous B(Q)B17 chickens regarding tumor growth and regression.

Main Methods:

• Pedigree matings were used to generate chickens with B(Q)B(Q), B(Q)B17, and B17B17 genotypes.
• Chickens were inoculated with different doses of subgroup A Rous sarcoma virus (RSV).
• Tumor size was monitored over 10 weeks, and a tumor profile index (TPI) was calculated.

Main Results:

• At a high RSV dose (30 pfu), no significant effect of B genotype on tumor growth was observed.
• At a lower RSV dose (15 pfu), B genotype significantly affected tumor growth patterns.
• Heterozygous B(Q)B17 chickens exhibited a lower TPI, indicating more tumor regression compared to homozygous B17B17 and B(Q)B(Q) genotypes.

Conclusions:

• The Major Histocompatibility (B) complex genotype influences the chicken's immune response to Rous sarcoma virus.
• Genetic complementation in B(Q)B17 heterozygotes enhances tumor regression under moderate viral challenge.
• These findings highlight the role of MHC in modulating immune responses to viral oncogenesis.